Ultima Genomics, Inc., a developer of ultra-high-throughput sequencing systems, continues its mission to enable sequencing at scale with the unveiling of the UG200 Series and next generation Solaris 2 ...
Hosted on MSN
From sample to insight with next-gen sequencing
Next-generation sequencing (NGS) is transforming research by delivering rapid, high-quality genetic data through streamlined workflows, automation, and advanced logistics. Eurofins Genomics combines ...
Delve Bio, a UCSF spin-out and pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, announced data underscoring the clinical impact of mNGS using Delve Detect to identify ...
Nearly half of people diagnosed with advanced cancer over a recent 5-year period did not undergo next-generation sequencing, according to results of a retrospective cohort study.Rates improved over ...
Metagenomic next‐generation sequencing (mNGS) is revolutionising infectious disease diagnosis by enabling an unbiased interrogation of all genetic material within a clinical sample. This approach ...
With the MiSeq™ i100 Series, Illumina continues to set the highest standards. Advancements in system design, sequencing chemistry, and data analysis deliver the simplest, fastest benchtop sequencing ...
This session presents two linked talks on CRISPR–Cas9 model generation and sequence validation. Christopher Raymond will discuss how direct zygote editing in mice and rats reduces timelines and costs ...
Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic coverage Introducing two new high-throughput instrument configurations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results